Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience.
- DOI
- 10.1186/s42155-026-00688-6
- Published
- 2026 Aug 14
- Container
- CVIR endovascular
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s42155-026-00688-6,
title = {Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience.},
author = {Ubaldi N and Khattar AS and Storey M and Adu J and Mailli L and Morgan R and Muir T and Ratnam L},
year = {2026},
journal = {CVIR endovascular},
doi = {10.1186/s42155-026-00688-6},
url = {https://doi.org/10.1186/s42155-026-00688-6}
}RIS
TY - JOUR TI - Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience. AU - Ubaldi N AU - Khattar AS AU - Storey M AU - Adu J AU - Mailli L AU - Morgan R AU - Muir T AU - Ratnam L PY - 2026 JO - CVIR endovascular DO - 10.1186/s42155-026-00688-6 UR - https://doi.org/10.1186/s42155-026-00688-6 ER -
APA
N, U., AS, K., M, S., J, A., L, M., R, M., T, M., & L, R. (2026). Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience.. CVIR endovascular. https://doi.org/10.1186/s42155-026-00688-6
Source records
- pubmed · retrieved 2026-09-26T03:35:46.683Z